A drug-eluting coronary stent system designed to treat coronary artery disease by delivering sirolimus to prevent restenosis. The stent is placed via percutaneous coronary intervention to restore blood flow in narrowed arteries.
Manufactured by
Hyderabad, India
Relisys Medical Devices Limited is one of the world s largest manufacturer of cardiovascular medical devices including Coronary Stent Systems – both Bare Metal Stent Systems Drug Eluting Stent Systems, PTCA Balloon Catheters, Angiographic Diagnostic Catheters, Guiding Catheters and Transcatheter Heart Valves. We constantly innovate and upgrade our portfolio to offer solutions to treat life-threatening heart diseases. Backed by strong R D, we constantly work on process product innovation thereby offering better solutions to the patients at affordable prices.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Easy-Flow Medical Tech Co., Ltd
China · 5 relevant products
Lepu Medical (Europe) Inc. Coöperatief U.A
Netherlands · 3 relevant products
Kossel Medtech (Suzhou) Co., Ltd.
China · 3 relevant products
Vasmed Technologies Ltd FZC
United Arab Emirates · 2 relevant products
USM Healthcare Medical Devices Factory JSC
Vietnam · 3 relevant products
Sonosemi Medical Co., Ltd.
China · 3 relevant products
TT MEDICAL, INC.
China · 3 relevant products
GENOSS CO., Ltd.
South Korea · 4 relevant products
Zhejiang Barty Medical Technology Co.,ltd.
China · 2 relevant products
AMT MEDICAL Inc
China · 1 relevant product
56 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 111 closest product alternatives
Shanghai Easy-Flow Medical Tech Co., Ltd · China
Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.
Lepu Medical (Europe) Inc. Coöperatief U.A · Netherlands
Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de novo coronary lesions requiring revascularization.
Kossel Medtech (Suzhou) Co., Ltd. · China
MiStent® is a sirolimus-eluting coronary stent with absorbable polymer coating designed for percutaneous coronary intervention. The cobalt chromium alloy structure provides sustained radial support and fatigue resistance for treating coronary artery stenosis. The drug-eluting mechanism reduces neointimal proliferation while the absorbable polymer eliminates chronic inflammatory response after healing.
Vasmed Technologies Ltd FZC · United Arab Emirates
Drug-eluting coronary stent for percutaneous transluminal coronary angioplasty reducing restenosis in atherosclerotic lesions.
Lepu Medical (Europe) Inc. Coöperatief U.A · Netherlands
Drug-eluting coronary stent system designed for percutaneous coronary intervention (PCI) in patients with coronary artery disease. The GuReater CoCr stent delivers sirolimus to inhibit restenosis while utilizing cobalt-chromium construction for enhanced radial strength and biocompatibility. Indicated for treatment of de novo coronary lesions in native vessels.
Lepu Medical (Europe) Inc. Coöperatief U.A · Netherlands
Polymer-free sirolimus-eluting coronary stent designed for percutaneous coronary intervention (PCI) in patients with coronary artery disease. The Nano+ system delivers sirolimus to inhibit neointimal proliferation while eliminating polymer-related inflammation, reducing restenosis risk. Indicated for coronary artery lesions requiring revascularization with improved biocompatibility.
USM Healthcare Medical Devices Factory JSC · Vietnam
A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.
Sonosemi Medical Co., Ltd. · China
Advanced stent platform with pharmaceutical coating for coronary applications. Reduces restenosis risk while maintaining vessel patency in patients with coronary artery disease.
TT MEDICAL, INC. · China
Drug-eluting and bare metal stent platforms for coronary artery disease treatment and acute coronary syndrome management.
GENOSS CO., Ltd. · South Korea
Stent device coated with medication for coronary, peripheral, and cerebrovascular applications. Used to expand narrowed or blocked blood vessels while preventing restenosis.
Zhejiang Barty Medical Technology Co.,ltd. · China
A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.
AMT MEDICAL Inc · China
Bioresorbable drug-eluting stent system designed for peripheral vascular intervention in patients with stenotic or occluded peripheral arteries. The stent gradually resorbs while delivering therapeutic agents to prevent restenosis, restoring blood flow in lower extremity and other peripheral vascular applications.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products